Lei Lei Wu - Page 53 - Endpoints News

about the author Lei Lei (pronounced "Lay Lay") Wu writes about cell therapy, genetic medicines, the science behind drug development, and occasionally cardiology. She also covers medical meetings, where she picks apart the latest clinical trial results. Lei Lei joined Endpoints as a news reporter in April 2022.

She graduated from Cornell University, where she studied biochemistry. She can be reached via email at [email protected] or by Signal at leileiwu.24 author articles Axolotls, chemical cocktails, and a new route for stem cell therapy — maybe New T cell immune response discovery points to 'out-of-box' cancer therapy options OrbiMed-backed biotech looks to challenge Vertex in cystic fibrosis by 'drugging the undruggable' A potential target for Alzheimer's treatment? Researchers unearth new immune response pathway Magenta feels the biotech blues, announces layoffs and clinical trial cuts Turning Point looks to challenge Pfizer, Roche with new early data for lead lung cancer drug FDA sends warning to rogue pharmacies selling Adderall illegally over the internet Aurion raises $120M in bid to scale cell therapy for form of blindness Patient death triggers a second clinical hold for Curis as FDA seeks more data Lei Lei (pronounced "Lay Lay") Wu writes about cell therapy, genetic medicines, the science behind drug development, and occasionally cardiology.

She also covers medical meetings, where she picks